Key terms
About AMPE
Ampio Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation and sexual dysfunction and CNS disease. The company was founded by David Bar-Or in December 2008 and is headquartered in Englewood, CO.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest AMPE news
Mar 28
10:59am ET
Biotech Alert: Searches spiking for these stocks today
Mar 25
5:01pm ET
Ampio announces NYSE delisting, SEC deregistration
Feb 28
4:02pm ET
Ampio Pharmaceuticals Ends Equity Distribution and Alters Strategy
Feb 15
9:42am ET
Ampio Pharmaceuticals Announces Nonclinical Study Success
Feb 14
5:48pm ET
Ampio reports results from OA-201 studies do not support IND submission
Jan 26
4:41am ET
Ampio Pharmaceuticals Announces At-The-Market Stock Offering
Jan 10
11:12am ET
Biotech Alert: Searches spiking for these stocks today
No recent press releases are available for AMPE
AMPE Financials
Key terms
Ad Feedback
AMPE Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
AMPE Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
